Federated Hermes’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.5K | Sell |
|
|||||
|
2025
Q1 | $51.9K | Sell |
|
|||||
|
2024
Q4 | $58.1K | Sell |
|
|||||
|
2024
Q3 | $1.31M | Sell |
|
|||||
|
2024
Q2 | $1.23M | Sell |
|
|||||
|
2024
Q1 | $1.58M | Sell |
|
|||||
|
2023
Q4 | $1.45M | Sell |
|
|||||
|
2023
Q3 | $1.78M | Buy |
|
|||||
|
2023
Q2 | $1.65M | Sell |
|
|||||
|
2023
Q1 | $2.98M | Buy |
|
|||||
|
2022
Q4 | $1.22M | Sell |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $4.08M | Sell |
|
|||||
|
2021
Q4 | $3.85M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $5.13M | Buy |
|
|||||
|
2020
Q4 | $4.57M | Buy |
|
|||||
|
2020
Q3 | $3.78M | Buy |
|
|||||
|
2020
Q2 | $1.14M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.63M | Sell |
|
|||||
|
2019
Q3 | $7.74M | Buy |
|
|||||
|
2019
Q2 | $4.96M | Buy |
|
|||||
|
2019
Q1 | $1.04M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $10.1M | Buy |
|
|||||
|
2018
Q1 | $1.41M | Buy |
|
|||||
|
2017
Q4 | $61K | Sell |
|
|||||
|
2017
Q3 | $1.17M | Buy |
|
|||||
|
2017
Q2 | $72K | Sell |
|
|||||
|
2017
Q1 | $58K | Sell |
|
|||||
|
2016
Q4 | $54K | Sell |
|
|||||
|
2016
Q3 | $64K | Sell |
|
|||||
|
2016
Q2 | $59K | Sell |
|
|||||
|
2016
Q1 | $70K | Buy |
|
|||||
|
2015
Q4 | $49K | Buy |
|